Timosaponin composition and application thereof in viral myocarditis treatment
The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. Accord...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XU YINGJIA XUE JINGUI HUANG RITAI |
| description | The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. According to the invention, the proliferation of myocardial tissue viruses can be inhibited obviously; the myocardial cells and tissues can be protected well; and the treatment efficiency of viral myocarditis is improved.
本发明公开了一种知母皂苷组合物，所述组合物含有知母皂苷AⅢ、知母皂苷BⅡ和知母皂苷N，其中知母皂苷AⅢ的重量百分含量为22%~34%，知母皂苷BⅡ的重量百分含量为18%~30%，知母皂苷N的重量百分含量为10%~17%，本发明组合物能够明显抑制心肌组织病毒增值，发挥对心肌细胞及组织的保护作用，提高病毒性心肌炎的治疗有效率。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN110882266A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN110882266A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN110882266A3</originalsourceid><addsrcrecordid>eNqNykEKwkAMQNFuXIh6h3gAwVYo3UpRXHXVfQnTFAMzSZgJgre3iAdw9fnwttUwctKCpsICQZNpYWcVQJkBzSIH_L4_KZMusLIXZ4yQ3howz6su4JnQE4nvq82CsdDh1111vN_G_nEi04mKYSAhn_qhrs9d1zRte738Yz6i6Dej</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Timosaponin composition and application thereof in viral myocarditis treatment</title><source>esp@cenet</source><creator>XU YINGJIA ; XUE JINGUI ; HUANG RITAI</creator><creatorcontrib>XU YINGJIA ; XUE JINGUI ; HUANG RITAI</creatorcontrib><description>The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. According to the invention, the proliferation of myocardial tissue viruses can be inhibited obviously; the myocardial cells and tissues can be protected well; and the treatment efficiency of viral myocarditis is improved.
本发明公开了一种知母皂苷组合物，所述组合物含有知母皂苷AⅢ、知母皂苷BⅡ和知母皂苷N，其中知母皂苷AⅢ的重量百分含量为22%~34%，知母皂苷BⅡ的重量百分含量为18%~30%，知母皂苷N的重量百分含量为10%~17%，本发明组合物能够明显抑制心肌组织病毒增值，发挥对心肌细胞及组织的保护作用，提高病毒性心肌炎的治疗有效率。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200317&DB=EPODOC&CC=CN&NR=110882266A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200317&DB=EPODOC&CC=CN&NR=110882266A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XU YINGJIA</creatorcontrib><creatorcontrib>XUE JINGUI</creatorcontrib><creatorcontrib>HUANG RITAI</creatorcontrib><title>Timosaponin composition and application thereof in viral myocarditis treatment</title><description>The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. According to the invention, the proliferation of myocardial tissue viruses can be inhibited obviously; the myocardial cells and tissues can be protected well; and the treatment efficiency of viral myocarditis is improved.
本发明公开了一种知母皂苷组合物，所述组合物含有知母皂苷AⅢ、知母皂苷BⅡ和知母皂苷N，其中知母皂苷AⅢ的重量百分含量为22%~34%，知母皂苷BⅡ的重量百分含量为18%~30%，知母皂苷N的重量百分含量为10%~17%，本发明组合物能够明显抑制心肌组织病毒增值，发挥对心肌细胞及组织的保护作用，提高病毒性心肌炎的治疗有效率。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNykEKwkAMQNFuXIh6h3gAwVYo3UpRXHXVfQnTFAMzSZgJgre3iAdw9fnwttUwctKCpsICQZNpYWcVQJkBzSIH_L4_KZMusLIXZ4yQ3howz6su4JnQE4nvq82CsdDh1111vN_G_nEi04mKYSAhn_qhrs9d1zRte738Yz6i6Dej</recordid><startdate>20200317</startdate><enddate>20200317</enddate><creator>XU YINGJIA</creator><creator>XUE JINGUI</creator><creator>HUANG RITAI</creator><scope>EVB</scope></search><sort><creationdate>20200317</creationdate><title>Timosaponin composition and application thereof in viral myocarditis treatment</title><author>XU YINGJIA ; XUE JINGUI ; HUANG RITAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN110882266A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>XU YINGJIA</creatorcontrib><creatorcontrib>XUE JINGUI</creatorcontrib><creatorcontrib>HUANG RITAI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XU YINGJIA</au><au>XUE JINGUI</au><au>HUANG RITAI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Timosaponin composition and application thereof in viral myocarditis treatment</title><date>2020-03-17</date><risdate>2020</risdate><abstract>The invention discloses a timosaponin composition comprising timosaponin AIII, timosaponin BII and timosaponin N. The weight percentage of the timosaponin AIII is 22% to 34%; the weight percentage ofthe timosaponin BII is 18 to 30%; and the weight percentage of the timosaponin N is 10 to 17%. According to the invention, the proliferation of myocardial tissue viruses can be inhibited obviously; the myocardial cells and tissues can be protected well; and the treatment efficiency of viral myocarditis is improved.
本发明公开了一种知母皂苷组合物，所述组合物含有知母皂苷AⅢ、知母皂苷BⅡ和知母皂苷N，其中知母皂苷AⅢ的重量百分含量为22%~34%，知母皂苷BⅡ的重量百分含量为18%~30%，知母皂苷N的重量百分含量为10%~17%，本发明组合物能够明显抑制心肌组织病毒增值，发挥对心肌细胞及组织的保护作用，提高病毒性心肌炎的治疗有效率。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN110882266A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Timosaponin composition and application thereof in viral myocarditis treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A36%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XU%20YINGJIA&rft.date=2020-03-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN110882266A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |